This work represents the UK experience with the second generation repositionable and retrievable valve Lotus (Boston Scientific, Natick, Massachusetts). It prospectively included 228 patients of mean age 81.4 ± 7.6 and a logistic EuroScore of 17.5 ± 12.4. From the total number of patients, 187 (82%) received the valve for aortic stenosis, 7<a href="https://solaci.org/en/2016/03/08/the-largest-series-with-lotus-valve-published-so-far/" title="Read more" >...</a>
Original Title: 1-Year Outcomes with the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis Results of the REPRISE II Study. Reference: Ian T. Meredith et al. J Am Coll Cardiol Intv. 2016;9(4):376-384. This analysis represents the first report at one year of 120 patients enrolled<a href="https://solaci.org/en/2016/02/23/one-year-outcomes-of-the-new-repositionable-and-retrievable-valve/" title="Read more" >...</a>
Resumen de las experiencias con Corevalve y nuevos dispositivos, tecnologías y desafíos para el implante percutáneo de válvula aórtica Dr. Elberhard Grube
Daniel Chamié2014-04-22 Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil
José A. Condado 2013-08-06 Director Cardiologia. IntervencionistaHosp. Miguel Pérez Carreño. IVSSCaracas- Venezuela
Eberhard Grube2014-10-30 MD, FACC, FSCAIUniversity Hospital, Dept of Medicine II, Bonn, GermanyStanford University, Palo Alto, California, USA
Eduardo de Marchena2014-10-30 M.D., F.A.C.C., F.A.C.P., F.S.C.A.I.Professor of Medicine & SurgeryAssociate Dean for International MedicineDirector of Interventional CardiologyUniversity of Miami Miller School of Medicine
Raúl GarcÃa-Rinaldo2014-08-08 MD, PhD, FACS Ponce School of Medicine, Ponce, PRMayaguez Medical Center, Mayaguez, PR
Fundamentos: Existem poucos dados comparando diferentes próteses valvares (THV) utilizadas nos implantes percutâneos de valva aórtica (TAVI), sendo que as próteses balão expansíveis parecem apresentar melhores resultados em relação às balão-expansíveis. O objetivo do estudo foi comparar a performance hemodinâmica entre as próteses aórticas Edwards Sapien XT (balão-expansível) e Medtronic CoreValve (auto-expansível) em pacientes de<a href="https://solaci.org/en/2015/06/24/protese-edwards-sapien-xt-e-medtronic-corevalve-demonstram-desempenho-equivalente-em-1-ano-em-pacientes-de-alto-risco-submetidos-a-tavi-2/" title="Read more" >...</a>
This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point was all-cause mortality and stroke at 30 days. 60 patients were included and the possibility for reposition was used 22 times between 12 recaptures and 10 re-sheathed of the valve. All maneuvers were carried out successfully. A 30<a href="https://solaci.org/en/2015/06/24/corevalve-evolut-r-ce-good-results-at-6-months-of-the-new-corevalve-repositionable/" title="Read more" >...</a>